RT @RichardPAConway: Chen et al. Adalimumab biosimilar (Amgevita) in JIA. Not a switch study, these are initiators. Expe
Tweet Content
Chen et al. Adalimumab biosimilar (Amgevita) in JIA. Not a switch study, these are initiators. Expected efficacy and safety outcomes of adalimumab seen here. Good to see more of these data to try and break down the last barriers to biosimilars @RheumNow #EULAR2022 POS1294 https://t.co/yoM2dIXLDQ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off